ACB Trent, Northern & Yorkshire Virtual Event - Current and Future Horizons for Lipids in North East England and Beyond

ACB Trent, Northern & Yorkshire Virtual Event - Current and Future Horizons for Lipids in North East England and Beyond

 

This event is now fully booked.
You may join the waiting list. We shall contact all registered delegates in the lead up to the event and if any wish to cancel then their places will be offered to those on the waiting list.

 

Morning Session: Chair - Dr Ahai Luvai, Newcastle upon Tyne Hospitals

0955 – 1000       Introduction
                           Dr Ahai Luvai, Newcastle upon Tyne Hospitals

1000 – 1030       Recent developments in FH genetic testing
                           Dr Ciaron McAnulty, Northern Genetics Service

1030 - 1100        Optimising the diagnosis of FH using bioinformatics
                           Rachel O’Leary, NICE external assessment centre

1100 - 1120        Advances in PCSK9i provision in the North East
                           Dr Purba Banerjee, Newcastle upon Tyne Hospitals

1120 – 1130       Break   

1130 – 1200       ApoB and β-quantification in the investigation of hypertriglyceridaemia
                           Dr Chris Boot, Newcastle upon Tyne Hospitals

1200 – 1230       An assay for atorvastatin: pitfalls and an unexpected surprise
                           Dr Liz Robinson, Northumbria NHS Foundation Trust

1230- 1330         Break   

Afternoon Session: Chair - Dr Fiona Jenkinson, Newcastle upon Tyne Hospitals

1330 – 1400       Screening for lysosomal acid lipase deficiency in dried blood spots
                           Dr Marianne Barr, Queen Elizabeth University Hospital, Glasgow

1400 – 1430       Non-cholesterol sterols in hyperlipidaemia and metabolic disease
                           Dr Ann Bowron, Newcastle upon Tyne Hospitals

1430 – 1450       An inherited cause of paediatric dyslipidaemia and hepatomegaly
                           Dr Chris Stockdale, Newcastle upon Tyne Hospitals

1450 – 1500       Break   

1500 – 1530       Next generation sequencing in the investigation of familial chylomicronaemia syndrome
                           Dr Paul Downie, Salisbury District Hospital and Bristol Royal Infirmary

1530 - 1600        Lipoprotein (a): When and how to measure it
                           Dr Dermot Neely, Newcastle upon Tyne Hospitals

1600                    Close    

 

Free for ACB members, £10 for non-members

 

 

This meeting is sponsored by Sanofi, Roche and Amgen
who have had no input into the content or organisation of this meeting

 

Sanofi.jpg Roche.png Amgen Cardiovascular.jpg